H.R. 5646 · 119th Congress (2025–2027)
Restoring Safeguards for Dangerous Abortion Drugs Act
To require the Secretary of Health and Human Services to approve a risk evaluation and mitigation strategy for mifepristone that is identical to the strategy previously approved, and for other purposes.
CRS summary not yet available.
Referred to committee
Latest actionReferred to committee
This bill’s path
This is H.R. 5646’s recorded path, not a universal congressional workflow.
How bills become lawAll actionsIntroduced
Passed House
Passed Senate
Sent to President
Signed into law
- Sponsor
- Rep. Mary E. Miller (R-IL-15)
- Cosponsors
8 cosponsors
6 original · 2 later
8 R
- Rep. Tim Burchett (R-TN-2)· Original · Sep 30, 2025
- Rep. Sheri Biggs (R-SC-3)· Original · Sep 30, 2025
- Rep. Pat Harrigan (R-NC-10)· Original · Sep 30, 2025
- Rep. Doug LaMalfa (R-CA-1)· Original · Sep 30, 2025
- Rep. Barry Moore (R-AL-1)· Original · Sep 30, 2025
- Rep. Randy K. Weber, Sr. (R-TX-14)· Original · Sep 30, 2025
- Rep. Michael Guest (R-MS-3)· Later · Oct 8, 2025
- Rep. Andy Harris (R-MD-1)· Later · Oct 31, 2025
- Policy area
- Health
On this page
Timeline
i
In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.
Introduced in House
Document: Introduced in House
Sources
- Congress.gov actionIntro-H
- Library of Congress
- Latest
Referred to committee
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sources
- Congress.gov action
- House floor actions
Committees
Text & titles
i
Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.
| Version | Date | Links |
|---|---|---|
| Introduced in House |
Titles (2)
Restoring Safeguards for Dangerous Abortion Drugs Act
Display title, Short title · Introduced in House
To require the Secretary of Health and Human Services to approve a risk evaluation and mitigation strategy for mifepristone that is identical to the strategy previously approved, and for other purposes.
Official title · Introduced in House